BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24162710)

  • 1. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
    Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
    Park MS; Lee SM
    Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.
    Lee SW; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    J Gastroenterol; 2010 May; 45(5):560-6. PubMed ID: 20035356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
    Ruys AT; Bennink RJ; van Westreenen HL; Engelbrecht MR; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2011 Apr; 13(4):256-62. PubMed ID: 21418131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
    Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM
    Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between TNM staging of primary cholangiocarcinoma and the maximum standard uptake value of (18)F-2-deoxy-D-glucose positron emission tomography with computerized tomography].
    Wang ZF; Lan XL; Xiao YR; Liu JP; Ji JS
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3104-3107. PubMed ID: 29081157
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
    Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
    J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
    Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer.
    Wang SL; Cao S; Sun YN; Wu R; Chi F; Tang MY; Jin XY; Chen XD
    Abdom Imaging; 2015 Oct; 40(8):3117-21. PubMed ID: 26350284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
    Kim NH; Lee SR; Kim YH; Kim HJ
    Korean J Radiol; 2020 Dec; 21(12):1355-1366. PubMed ID: 32767862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma.
    Lee EJ; Chang SH; Lee TY; Yoon SY; Cheon YK; Shim CS; So Y; Chung HW
    Anticancer Res; 2015 Dec; 35(12):6985-91. PubMed ID: 26637926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
    Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma.
    Pak K; Kim SJ; Kim IJ; Kim DU; Kim K; Kim H; Kim SJ
    Nuklearmedizin; 2014; 53(2):26-31. PubMed ID: 24305850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of
    Lim CH; Moon SH; Cho YS; Choi JY; Lee KH; Hyun SH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1705-1712. PubMed ID: 31049603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
    Kluge R; Schmidt F; Caca K; Barthel H; Hesse S; Georgi P; Seese A; Huster D; Berr F
    Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy.
    Ikushima H; Dong L; Erasmus J; Allen P; McAleer MF; Zhuang Y; Sasaki R; Komaki R
    J Radiat Res; 2010; 51(4):465-71. PubMed ID: 20508373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
    Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
    Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.